HA-100

CAS No. 84468-24-6

HA-100( —— )

Catalog No. M20991 CAS No. 84468-24-6

HA-100 is an inhibitor of protein kinase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 60 In Stock
5MG 54 In Stock
10MG 92 In Stock
25MG 206 In Stock
50MG 362 In Stock
100MG 529 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HA-100
  • Note
    Research use only, not for human use.
  • Brief Description
    HA-100 is an inhibitor of protein kinase.
  • Description
    HA-100 is an inhibitor of protein kinase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    PKA
  • Recptor
    PKA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    84468-24-6
  • Formula Weight
    277.34
  • Molecular Formula
    C13H15N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:150 mg/mL (540.85 mM)
  • SMILES
    O=S(=O)(c1cccc2cnccc12)N1CCNCC1
  • Chemical Name
    5-Piperazin-1-ylsulfonylisoquinoline;dihydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hagiwara M Inagaki M Watanabe M et al. Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors isoquinolinesulfonamide derivatives.[J]. Molecular Pharmacology 1987 32(1):7.
molnova catalog
related products
  • Synaptamide

    An endogenous DHA metabolite that promotes neurite growth, synaptogenesis, and synaptic function both in vitro and in vivo.

  • GSK-J4 Hydrochloride

    GSK-J4 is a cell permeable, potent and selective histone demethylase(JMJD3 )inhibitor. is an ethyl ester derivative of the GSK-J1 with an IC50 value greater than 50 μM in vitro.

  • Rp-cAMPS sodium

    Rp-cAMPS sodium is a phosphorothioate analog of cAMP, a protein kinase A inhibitor and a membrane-permeable cAMP antagonist that inhibits cAMP-dependent protein kinases by blocking cAMP-induced conformational transitions, and can be used in the study of cardiovascular diseases.